Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats
- 1 July 1998
- journal article
- Published by Elsevier in Life Sciences
- Vol. 63 (7) , 511-521
- https://doi.org/10.1016/s0024-3205(98)00302-6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- A Novel Cardiac-Restricted Target for DoxorubicinJournal of Biological Chemistry, 1997
- Effects of doxorubicin on cardiomyocytes with reduced level of superoxide dismutaseLife Sciences, 1995
- Combination therapy with probucol prevents adriamycin-induced cardiomyopathyJournal of Molecular and Cellular Cardiology, 1995
- Anthracycline Antibiotics in Cancer TherapyDrugs, 1994
- Cardiac toxicity 4 to 20 years after completing anthracycline therapyPublished by American Medical Association (AMA) ,1991
- Subcellular effects of adriamycin in the heart: A concise reviewJournal of Molecular and Cellular Cardiology, 1987
- Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycinBiochemical Pharmacology, 1985
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973